Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 8Ovarian Neoplasms 7Rectal Neoplasms 4Colonic Neoplasms 4Peritoneal Neoplasms 2Pancreatic Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Robotic 1Prostatic Neoplasms 1Pancreatic Neuroendocrine Tumors 1Ovarian Cysts 1Neoplasms 1Myofibroma 1Kidney Neoplasms 1Genital Neoplasms, Female 1Gastrointestinal Stromal Tumors 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Endometrial Adenocarcinoma 1Drug-Related Side Effects and Adverse Reactions 1Diverticulitis 1Crohn Disease 1Colonic Polyps 1

Interventions

Paclitaxel 4Carboplatin 4Pemetrexed 2Palliative Care 2Gemcitabine 2temsirolimus 1rucaparib 1pembrolizumab 1niraparib 1nintedanib 1nilotinib 1liposomal doxorubicin 1fosaprepitant 1atezolizumab 1argatroban 1Topotecan 1Thrombopoietin 1Palonosetron 1Ocoxin 1Laparoscopy 1Heparin, Low-Molecular-Weight 1Filgrastim 1Electrocardiography 1Educational Status 1Dexamethasone 1Darbepoetin alfa 1Cognitive Behavioral Therapy 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Genital Neoplasms, Female × Laparoscopy × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡